9D7P image
Deposition Date 2024-08-16
Release Date 2025-06-04
Last Version Date 2025-06-04
Entry Detail
PDB ID:
9D7P
Title:
Cryo-EM structure of BG505 DS-SOSIP.664 with 2 CH103 Fabs bound
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.37 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Surface protein gp120
Chain IDs:A, C, E
Chain Length:496
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:Transmembrane protein gp41
Chain IDs:B, D, F
Chain Length:162
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:CH103 Fab light chain
Chain IDs:G, I
Chain Length:278
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:CH103 Fab heavy chain
Chain IDs:H, J
Chain Length:245
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation

Abstact

Although most broadly neutralizing antibodies (bNAbs) specific for the CD4-binding site (CD4-BS) of HIV-1 interact with a single gp120 protomer, a few mimic the quaternary binding mode of CD4, making contact with a second protomer through elongated heavy chain framework 3 (FRH3) or complementarity-determining region 1 (CDRH1) loops. Here, we show that a CDRH3-dominated anti-CD4-BS bNAb, CH103, establishes quaternary interaction despite regular-length FRH3 and CDRH1. This quaternary interaction is critical for neutralization and is primarily mediated by two FRH3 acidic residues that were sequentially acquired and subjected to strong positive selection during CH103 maturation. Cryoelectron microscopy (cryo-EM) structures confirmed the role of the two FRH3 acidic residues in mediating quaternary contact and demonstrated that CH103 reaches the adjacent gp120 protomer by virtue of its unique angle of approach. Thus, the acquisition of quaternary interaction may constitute a key step in the lineage maturation of a broad and potent HIV-1 neutralizing antibody.

Legend

Protein

Chemical

Disease

Primary Citation of related structures